Advancing Management Goals in Primary Biliary Cholangitis (PBC): Biochemical Control, Residual Risk and Symptom Burden

Nov 08 2026
Convention Center: TLM Theater 2, Hall F
12:30 PM - 1:00 PM

Description

This interactive case-based session explores the evolving management goals in primary biliary cholangitis (PBC), highlighting the limitations of traditional biochemical response thresholds and the importance of residual risk assessment. Through real-world patient scenarios, faculty will examine alkaline phosphatase normalization, symptom burden, and comprehensive management strategies.

Industry Supporter: Ipsen